Stock CLS CLICKS GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Clicks Group Limited

Equities

CLS

ZAE000134854

Drug Retailers

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
291.5 ZAR -1.19% Intraday chart for Clicks Group Limited +1.37% -10.49%
Apr. 25 Clicks Group Limited Reports Earnings Results for the Half Year Ended February 29, 2024 CI
Apr. 25 Transcript : Clicks Group Limited, H1 2024 Earnings Call, Apr 25, 2024

Valuation

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 50,275 57,192 74,296 72,708 66,179 70,083 - -
Enterprise Value (EV) 1 47,662 55,040 72,089 70,693 63,724 68,192 67,905 67,493
P/E ratio 29.6 x 30.6 x 40.7 x 28.9 x 26.2 x 25 x 22.6 x 20.3 x
Yield 2.24% 1.96% 1.62% 2.14% 2.48% 2.6% 2.91% 3.24%
Capitalization / Revenue 1.6 x 1.66 x 1.99 x 1.84 x 1.59 x 1.54 x 1.41 x 1.29 x
EV / Revenue 1.52 x 1.6 x 1.93 x 1.79 x 1.53 x 1.5 x 1.37 x 1.25 x
EV / EBITDA 17.7 x 14.1 x 17.3 x 14.2 x 12.4 x 11.9 x 10.7 x 9.63 x
EV / FCF - 59.4 x 44.4 x 65.5 x 26.8 x 20.4 x 16.5 x 14.9 x
FCF Yield - 1.68% 2.25% 1.53% 3.73% 4.91% 6.08% 6.73%
Price to Book 10.2 x 11 x 15.5 x 12.8 x 11.1 x 11.9 x 10.8 x 9.8 x
Nbr of stocks (in thousands) 252,640 248,663 245,557 243,970 241,971 238,062 - -
Reference price 2 199.0 230.0 302.6 298.0 273.5 294.4 294.4 294.4
Announcement Date 10/24/19 10/22/20 10/27/21 10/20/22 10/26/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 31,352 34,364 37,339 39,587 41,622 45,595 49,738 54,173
EBITDA 1 2,692 3,898 4,157 4,971 5,142 5,724 6,350 7,005
EBIT 1 2,321 2,767 2,897 3,325 3,623 4,117 4,572 5,056
Operating Margin 7.4% 8.05% 7.76% 8.4% 8.7% 9.03% 9.19% 9.33%
Earnings before Tax (EBT) 1 2,364 2,584 2,642 3,639 3,471 3,879 4,272 4,724
Net income 1 1,703 1,880 1,838 2,523 2,538 2,818 3,112 3,459
Net margin 5.43% 5.47% 4.92% 6.37% 6.1% 6.18% 6.26% 6.39%
EPS 2 6.718 7.514 7.438 10.33 10.42 11.75 13.02 14.48
Free Cash Flow 1 - 925.9 1,622 1,079 2,380 3,350 4,125 4,543
FCF margin - 2.69% 4.34% 2.73% 5.72% 7.35% 8.29% 8.39%
FCF Conversion (EBITDA) - 23.75% 39.02% 21.71% 46.29% 58.53% 64.96% 64.86%
FCF Conversion (Net income) - 49.25% 88.25% 42.79% 93.79% 118.88% 132.58% 131.33%
Dividend per Share 2 4.450 4.500 4.900 6.370 6.790 7.642 8.561 9.551
Announcement Date 10/24/19 10/22/20 10/27/21 10/20/22 10/26/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: August 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2
Net sales 1 16,857 17,508 18,134 19,205 - 20,030
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income - - - - 1,206 -
Net margin - - - - - -
EPS 2 3.380 4.134 3.589 3.849 4.928 5.399
Dividend per Share - - - - - -
Announcement Date 4/23/20 10/22/20 4/23/21 10/27/21 4/28/22 10/20/22
1ZAR in Million2ZAR
Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 2,614 2,152 2,207 2,015 2,455 1,891 2,178 2,591
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - 926 1,622 1,079 2,380 3,350 4,125 4,543
ROE (net income / shareholders' equity) 36.5% 37.7% 38.2% 48% 43.6% 46.6% 46.9% 47.1%
ROA (Net income/ Total Assets) 13.8% 12.4% - - 13.8% 14.4% 14.7% 15%
Assets 1 12,322 15,172 - - 18,388 19,625 21,183 23,086
Book Value Per Share 2 19.50 20.90 19.60 23.40 24.70 24.80 27.20 30.00
Cash Flow per Share 2 7.440 6.060 9.360 7.850 13.60 15.30 17.40 19.30
Capex 1 647 591 690 838 930 910 901 932
Capex / Sales 2.06% 1.72% 1.85% 2.12% 2.23% 2% 1.81% 1.72%
Announcement Date 10/24/19 10/22/20 10/27/21 10/20/22 10/26/23 - - -
1ZAR in Million2ZAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Clicks Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
294.4 ZAR
Average target price
318.1 ZAR
Spread / Average Target
+8.07%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
CLICKS GROUP LIMITED Stock Clicks Group Limited
-10.49% 3.73B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.86% 14.96B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-22.76% 11.07B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.74% 6.13B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-22.17% 6.08B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-10.91% 5.98B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+0.88% 4.76B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+53.60% 4.36B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-12.53% 3.43B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-7.34% 3.02B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. CLS Stock
  4. Financials Clicks Group Limited